Apolipoprotein CIII and Highly Active AntiretroviralTherapy (HAART) -induced hypertriglyceridemia
S Badiou; AM Dupuy; V Baillat; J Fabre; MD Tür; JP Cristol; J Reynes
Clinical Laboratory 49(1-2): 11-13
2003
ISSN/ISBN: 1433-6510 PMID: 12593470 Document Number: 8293
Document emailed within 1 workday
Related Documents
Alsayed, N.; Drüeke, T.B.; Lacour, B. 1988: Purification of anti-apolipoprotein CIIi antibodies by exploiting their affinity for apolipoprotein CIIi linked to polyacrylamide gel after isoelectric focusing Clinical Chemistry 34(1): 49-52Chandrasekhar, A.; Gupta, A. 2011: Nutrition and disease progression pre-highly active antiretroviral therapy (HAART) and post-HAART: can good nutrition delay time to HAART and affect response to HAART? American Journal of Clinical Nutrition 94(6): 1703s-1715s
Edlin, B.R. 1999: Change of HAART. Highly active antiretroviral therapy Lancet 353(9167): 1888
Nelwan, E.J. 2014: Adherence to highly active antiretroviral therapy (HAART) in HIV/AIDS patient Acta Medica Indonesiana 46(4): 273-274
Domingos, H.; Cunha, R.V.ân.d.; Paniago, A.M.M.; Martins, D.M.; Elkhoury, E.B.ão.; Souza, A.S.d. 2009: Metabolic effects associated to the highly active antiretroviral therapy (HAART) in AIDS patients Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 13(2): 130-136
Jáuregui Camargo, L.; Ruiz-Palacios, G.; Guerrero Almeida, L.; Niño Oberto, S.; Peasey, A.; Sierra Madero, J. 2003: Evaluation of highly active antiretroviral therapy (HAART) in a cohort of patients with HIV infection in Mexico Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 55(1): 10-17
Lapphra, K.; Vanprapar, N.; Phongsamart, W.; Chearskul, P.; Chokephaibulkit, K. 2005: Dyslipidemia and lipodystrophy in HIV-infected Thai children on highly active antiretroviral therapy (HAART) Journal of the Medical Association of Thailand 88(7): 956-966
Pomerantz, R.J. 1999: HIV patients receiving HAART therapy can still transmit the virus. Highly active antiretroviral chemotherapy American Family Physician 59(10): 2855
Bedingfield, N.; Kipp, W.; Kaler, A.; Rubaale, T. 2014: Revelations of HIV-infected patients treated with highly active antiretroviral therapy (HAART) in rural Uganda Aids Care 26(1): 75-78
Sophan, S.; Meng, C.Y.; Pean, P.; Harwell, J.; Hutton, E.; Trzmielina, S.; Somasundaran, M.; Luzuriaga, K.; Pugatch, D. 2010: Virologic and immunologic outcomes in HIV-infected Cambodian children after 18 months of highly active antiretroviral therapy (HAART) Southeast Asian Journal of Tropical Medicine and Public Health 41(1): 126-137
Da Silva, C.A.L.; Dourado, I.ês.; Dahia, S.R.; Harzheim, E.; Rutherford, G.W. 2008: Oral manifestations of HIV infection in patients receiving highly active antiretroviral therapy (HAART) in Bahia, Brazil Journal of Public Health Dentistry 68(3): 178-181
Sophan, S.; Meng, C.Y.; Pean, P.; Harwell, J.; Hutton, E.; Trzmielina, S.; Somasundaran, M.; Luzuriaga, K.; Pugatch, D. 2010: Virologic and immunologic outcomes in HIV-infected Cambodian children after 18 months of highly active antiretroviral therapy (HAART) Southeast Asian Journal of Tropical Medicine and Public Health 41(1): 126-137
Coleman, R.T.; Gonzalez, P.A.; Funke, H.; Assmann, G.; Levy-Wilson, B.; Frossard, P.M. 1986: Polymorphisms in the apolipoprotein AI-CIIi gene complex Molecular Biology and Medicine 3(3): 213-228
Tuuli, M.G.; Duong, T.H.; Yost, N.P.; Ellis, J.; Burke, C.V.; Basanta-Henry, P.L.; Lindsay, M. 2011: Postpartum contraceptive preferences of HIV-infected women in the era of highly active antiretroviral therapy (HAART) and scheduled cesarean deliveries Contraception 84(2): 150-154
Miiro, G.; Todd, J.; Mpendo, J.; Watera, C.; Munderi, P.; Nakubulwa, S.; Kaddu, I.; Rutebarika, D.; Grosskurth, H. 2009: Reduced morbidity and mortality in the first year after initiating highly active anti-retroviral therapy (HAART) among Ugandan adults Tropical Medicine and International Health: Tm and Ih 14(5): 556-563
Akinbo, F.O.; Omoregie, R. 2012: Plasmodium falciparum infection in HIV-infected patients on highly active antiretroviral therapy (HAART) in Benin City, Nigeria Journal of Research in Health Sciences 12(1): 15-18
Farrant, L.; Gwyther, L.; Dinat, N.; Mmoledi, K.; Hatta, N.; Harding, R. 2012: The prevalence and burden of pain and other symptoms among South Africans attending highly active antiretroviral therapy (HAART) clinics South African Medical Journal 102(6): 499-500
Hengge, U.R.; Goos, M.; Esser, S.; Exner, V.; Dötterer, H.; Wiehler, H.; Borchard, C.; Müller, K.; Beckmann, A.; Eppner, M.T.; Berger, A.; Fiedler, M. 1998: Randomized, controlled phase II trial of subcutaneous interleukin-2 in combination with highly active antiretroviral therapy (HAART) in HIV patients Aids 12(17): F225-F234
Luo, J.; Jing, D.; Kozak, I.; Huiming, Z.; Siying, C.; Yezhen, Y.; Xin, Q.; Luosheng, T.; Adelman, R.A.; Forster, S.H. 2013: Prevalence of ocular manifestations of HIV/AIDS in the highly active antiretroviral therapy (HAART) era: a different spectrum in Central South China Ophthalmic Epidemiology 20(3): 170-175
Breuckmann, F.; Neumann, T.; Kondratieva, J.; Wieneke, H.; Ross, B.; Nassenstein, K.; Barkhausen, J.; Kreuter, A.; Brockmeyer, N.; Erbel, R. 2005: Dilated cardiomyopathy in two adult human immunodeficiency positive (HIV+) patients possibly related to highly active antiretroviral therapy (HAART) European Journal of Medical Research 10(9): 395-399